Table 1 Baseline Characteristics of the Studies Included in the Systematic Review and Meta-analysis
Publication | Country | Sample Source | Study Design | Follow-up Duration, years | Sample Size | Age, years | Male, % | Exposure indicator | CVD Outcomes | |
|---|---|---|---|---|---|---|---|---|---|---|
Assessed | Cases | |||||||||
Park, 2021 [14] | South Korean | KNHANES (2014–2018)a | Cross-sectional study | 0 | 6785 | ≥65 | 44.57 | Total sedentary time | CVD morbidity | 914 |
Hamer, 2020 [11] | UK | UK Biobank (2006–2010)a | Prospective study | 10.4 | 479,658 | 56.5 ± 8.0 | 45.7 | Screen time | CVD mortality | 1437 |
Liu, 2020 [13] | China | China-PAR (1998, 2000–2001, 2007–2008)a | Prospective study | 5.8 | 93,110 | 52.8 ± 12.3 | 39.4 | Total sedentary time | CVD morbidity or CVD mortality | 3799 |
Tu, 2020 [18] | China | Self-sampling | Prospective study | 5.9 | 3019 | ≥18 | 42.9 | Total sedentary time | CVD morbidity and mortality | 143 |
Bellettiere, 2019 [19] | US | OPACH (2012–2014)a | Prospective study | 4.9 | 5638 | 79.0 ± 7.0 | 0 | Total sedentary time | CVD morbidity and mortality | NA |
Garcia, 2019 [21] | US | JHS (2000–2004)a | Prospective study | 8.4 | 3592 | ≥21 | 36.7–40.8 | Screen time & Occupational sitting time | CVD morbidity | 168 |
Stamatakis, 2019 [15] | Australia | The 45 and Up study (2006–2009)a | Prospective study | 7.4 | 148,836 | ≥45 | 44.5 | Total sitting time | CVD mortality | 1403 |
Patel, 2018 [26] | US | CPS-II Nutrition study (1992)a | Prospective study | 20.3 | 127,554 | 50–74 | 44.38 | Leisure sedentary time | CVD mortality | 16,083 |
Morales, 2018 [9] | UK | UK Biobank (2007–2010)a | Prospective study | 4.1 | 205,338 | 40–69 | NA | Screen time | CVD morbidity | 9660 |
Dohrn, 2017 [16] | Sweden | ABC study (2001–2002)a | Prospective study | 14.2 | 851 | 66.7 ± 10.2 | 44 | Total sedentary time | CVD mortality | 24 |
Engelen, 2017 [27] | Australia | ANNPAS (2011–2012)a | Cross-sectional study | 0 | 9435 | ≥18 | NA | Total sitting time | CVD morbidity | NA |
Cumming, 2016 [22] | Australia | AusDiab (1999–2000)a | Prospective study | 12 | 9104 | 50.7 ± 13.4 to 67.4 ± 13.0 | 44.33 | Screen time | CVD morbidity | 126 |
Evenson, 2016 [17] | US | NHANES (2003–2006)a | Prospective study | 6.7 | 3809 | 55.3 | 45.4 | Total sedentary time, screen time | CVD mortality | 107 |
Grace, 2016 [24] | Australia | AusDiab (1999–2000)a | Prospective study | 13.6 | 8907 | ≥18 | 44.3 | Screen time | CVD mortality | 209 |
McDonnell, 2016 [23] | US | REGARDS (2003–2007)a | Prospective study | 7.1 | 22,257 | ≥45 | 44.5 | Screen time | CVD morbidity | 727 |
Moller, 2016 [28] | Denmark | DWECS (1990)a | Prospective study | 12.2 | 11,996 | 18–59 | NA | Occupational sitting time | CVD morbidity and mortality | 510 |
Borodulin, 2015 [20] | Finland | National FINRISK 2002 study (2002)a | Prospective study | 8.6 | 4516 | 47.0 ± 13.0 | 44.5 | Total sedentary time | CVD morbidity and mortality | 183 |
Ikehara, 2015 [25] | Japan | JACC study (1988–1990)a | Prospective study | 19.2 | 85,899 | 40–79 | 41.9 | Screen time | CVD mortality | 5835 |
Keadle, 2015 [7] | US | NIH-AARP Health Study (1995–1996)a | Prospective study | 14.1 | 221,426 | 50–71 | 57 | Screen time | CVD mortality | 7340 |